The leading causes of death in the United States (U.S.) are heart disease and strokes.…
Author: Emma Yasinski
I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.
You have cancer. If that wasn’t terrifying enough, you now face a litany of medical choices, treatments, and drugs. As you try to educate yourself about those options, you also have to weigh the unpredictable nature of their side effects. Unfortunately, the side effects listed on the drug’s label don’t tell us much about what it’s really like to take a drug. A new article published in Undark explains how and why the information patients get on side effects often seems to minimize that challenge that side effects can pose. The article uses cancer drugs as an example and is…
Regular MedShadow readers are likely familiar with the idea of deprescribing—the process of reducing the number or dose of drugs a person is taking. MedShadow has written about the phenomenon before. But, while the idea of taking fewer medications is simple, the process of deprescribing while balancing risks versus benefits is complicated. Some medications have withdrawal symptoms, and tapering may take time. The Therapeutics Initiative at the University of British Columbia is hosting a series of webinars with healthcare professionals sharing real-life stories of their own patients whose medications they were able to reduce, and what happened when they did.…
Shalamar suffered from chronic insomnia. She couldn’t fall asleep after her late-night shifts as a server at a New York City bar. To address the insomnia, she sought advice from a psychiatrist who prescribed pills and told her to take them both at night and in the morning. She thought it was odd that she would need to take a pill to help her sleep during the day, but her doctor said that is how the medicine worked. She followed the doctor’s recommendations, though. “It did help me to sleep. I slept like a rock,” she says. What her doctor…
A new chemotherapy drug promises to treat some patients with pediatric acute lymphoblastic leukemia (ALL) who have been unable to take the other two other chemo medicines because one can cause allergic reactions and the other is frequently in short supply. This summer, the Food and Drug Administration (FDA) fast-tracked the approval of Rylaze, a newer version of the chemo drug Erwinaze to treat ALL (leukemia) , made by Jazz Pharmaceuticals, which was previously distributed Erwinaze. The agency approved Rylaze based on an ongoing Phase 2/3 trial of about 102 patients, with an average age of 10. The rare disease…
The incidence of depression and anxiety has surged among adults in the United States over the course of the COVID-19 pandemic, according to the Centers for Disease Control and Prevention (CDC). The CDC survey suggested that from 2019 to 2020, symptoms of anxiety disorders and depression have tripled and quadrupled, respectively. As you might expect, prescriptions for antidepressant and antianxiety drugs also have spiked, according to the telehealth platform iPrescribe. While many patients with severe or chronic depression or anxiety may need to continue using these medications long term, you may think that, given the return of opportunities for working…
Anxiety Medications Fast Facts
Anxiety is a normal reaction to stress, but for some people, it can become overwhelming and debilitating. People with types of anxiety disorder feel apprehensive and uneasy, and it’s common for them to experience negative thoughts that make them more fearful. According to the National Institute of Mental Health (NIMH): More than 40 million American adults ages 18 and older have an anxiety disorder, and nearly one-third of adults will experience an anxiety disorder at some point in their life. Anxiety disorders frequently co-occur with depressive disorders or substance abuse. Most people with an anxiety disorder also have depression. Most…
About MedShadow
MedShadow Foundation is an independent nonprofit health & wellness journalism organization focused on helping to protect lives from the side effects of medication and lower risk with alternative health options.
We help protect your life and the lives of your family by making sure you have the information you need to make informed decisions about the risks, benefits and alternatives to medicines.
Even though MedShadow is nonprofit, we refuse to accept support from pharmaceutical companies or medical device manufacturers. You can be sure that our information is free from the influence of pharmaceutical companies.
FIND ARTICLES
Conditions
Symptoms & Concerns
Medications
SUPPORT
Contribute
Donate
Contact
MedShadow Foundation does not provide medical advice, diagnosis or treatment.
This site complies with the HONcode standard for trustworthy health information.
MedShadow Foundation is a registered 501(c)(3) non-profit organization. MedShadow does not accept advertising or contributions from pharmaceutical companies, medical device manufacturers or political action organizations.
Copyright © 2022, MedShadow Foundation. all rights reserved. Designed by Dante Steward